Jiaoli Guo

1.3k total citations
16 papers, 1.1k citations indexed

About

Jiaoli Guo is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Jiaoli Guo has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Jiaoli Guo's work include MicroRNA in disease regulation (8 papers), RNA Interference and Gene Delivery (3 papers) and Cancer-related molecular mechanisms research (3 papers). Jiaoli Guo is often cited by papers focused on MicroRNA in disease regulation (8 papers), RNA Interference and Gene Delivery (3 papers) and Cancer-related molecular mechanisms research (3 papers). Jiaoli Guo collaborates with scholars based in China, United States and Switzerland. Jiaoli Guo's co-authors include Xiaoming Xie, Laisheng Li, Jie Gao, Yanan Kong, Hailin Tang, Xinhua Xie, Jinmei Luo, Minqing Wu, Qi Su and Weidong Wei and has published in prestigious journals such as PLoS ONE, Molecular and Cellular Biology and Clinical Cancer Research.

In The Last Decade

Jiaoli Guo

16 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiaoli Guo China	13	882	687	139	81	79	16	1.1k
Songcheng Zhu China	19	1.2k 1.3×	467 0.7×	172 1.2×	53 0.7×	37 0.5×	35	1.3k
Zhifan Jia China	21	2.0k 2.2×	1.6k 2.4×	166 1.2×	66 0.8×	34 0.4×	38	2.4k
Atsuhiro Kishimoto Japan	16	1.1k 1.2×	358 0.5×	245 1.8×	130 1.6×	22 0.3×	26	1.3k
Laura Zannini Italy	16	817 0.9×	203 0.3×	335 2.4×	68 0.8×	71 0.9×	24	1.0k
Eva M. Goellner United States	14	935 1.1×	210 0.3×	345 2.5×	55 0.7×	61 0.8×	17	1.2k
Chao Dai China	16	807 0.9×	266 0.4×	352 2.5×	76 0.9×	30 0.4×	33	1.1k
Sumaiyah K. Rehman United States	8	740 0.8×	420 0.6×	386 2.8×	238 2.9×	29 0.4×	12	1.1k
Keiko Doi Japan	20	566 0.6×	199 0.3×	155 1.1×	41 0.5×	31 0.4×	51	877
Hyeok-Gu Kang South Korea	17	653 0.7×	324 0.5×	224 1.6×	55 0.7×	24 0.3×	24	934

Countries citing papers authored by Jiaoli Guo

Since Specialization

Citations

This map shows the geographic impact of Jiaoli Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaoli Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaoli Guo more than expected).

Fields of papers citing papers by Jiaoli Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiaoli Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaoli Guo. The network helps show where Jiaoli Guo may publish in the future.

Co-authorship network of co-authors of Jiaoli Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Jiaoli Guo. A scholar is included among the top collaborators of Jiaoli Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiaoli Guo. Jiaoli Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Tang, Hailin, Min Deng, Yunyun Tang, et al.. (2013). miR-200b and miR-200c as Prognostic Factors and Mediators of Gastric Cancer Cell Progression. Clinical Cancer Research. 19(20). 5602–5612. 145 indexed citations

Li, Laisheng, Bo Wang, Dong Wang, et al.. (2013). Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer. Molecular Cancer. 12(1). 163–163. 101 indexed citations

Kong, Yanan, Lu Yang, Hailin Tang, et al.. (2013). A Nation-Wide Multicenter Retrospective Study of the Epidemiological, Pathological and Clinical Characteristics of Breast Cancer In Situ in Chinese Women in 1999 - 2008. PLoS ONE. 8(11). e81055–e81055. 10 indexed citations

Gao, Jie, Laisheng Li, Minqing Wu, et al.. (2013). MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1. PLoS ONE. 8(6). e65138–e65138. 107 indexed citations

Guo, Jiaoli, Xinhua Xie, Laisheng Li, et al.. (2013). Synergistic effects of curcumin with emodin against the proliferation and invasion of breast cancer cells through upregulation of miR-34a. Molecular and Cellular Biochemistry. 382(1-2). 103–111. 94 indexed citations

Kong, Yanan, Junye Wang, Wanli Liu, et al.. (2013). Cytokeratin19-2g2, a Novel Fragment of Cytokeratin19 in Serum, Indicating a More Invasive Behavior and Worse Prognosis in Breast Cancer Patients. PLoS ONE. 8(2). e57092–e57092. 5 indexed citations

Tang, Hailin, Yanan Kong, Jiaoli Guo, et al.. (2013). Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22. Cancer Letters. 340(1). 72–81. 102 indexed citations

Tang, Hailin, Xinhua Xie, Jiaoli Guo, et al.. (2013). Efficient systemic DNA delivery to the tumor by self-assembled nanoparticle. Journal of Nanoparticle Research. 16(1). 2 indexed citations

Gao, Jie, Laisheng Li, Minqing Wu, et al.. (2013). Correction: MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1. PLoS ONE. 8(12). 17 indexed citations

10.

Wu, Minqing, Weidong Wei, Xiangsheng Xiao, et al.. (2012). Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer. Medical Oncology. 29(5). 3240–3249. 72 indexed citations

11.

Li, Laisheng, Xinhua Xie, Min Liu, et al.. (2012). Targeted Expression of miR-34a Using the T-VISA System Suppresses Breast Cancer Cell Growth and Invasion. Molecular Therapy. 20(12). 2326–2334. 88 indexed citations

12.

Li, Laisheng, et al.. (2012). MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1. Clinical and Experimental Medicine. 13(2). 109–117. 273 indexed citations

13.

Xie, Xinhua, Laisheng Li, Xiangsheng Xiao, et al.. (2012). Targeted Expression of BikDD Eliminates Breast Cancer with Virtually No Toxicity in Noninvasive Imaging Models. Molecular Cancer Therapeutics. 11(9). 1915–1924. 22 indexed citations

14.

Xie, Xinhua, Jiaoli Guo, Yanan Kong, et al.. (2011). Targeted expression of Escherichia coli purine nucleoside phosphorylase and Fludara® for prostate cancer therapy. The Journal of Gene Medicine. 13(12). 680–691. 17 indexed citations

15.

Kong, Yanan, Shuqin Dai, Xinhua Xie, et al.. (2011). High serum HER2 extracellular domain levels: correlation with a worse disease-free survival and overall survival in primary operable breast cancer patients. Journal of Cancer Research and Clinical Oncology. 138(2). 275–284. 20 indexed citations

16.

Yuan, Zhongmin, Shoufang Gong, Jingyan Luo, et al.. (2009). Opposing Roles for ATF2 and c-Fos in c-Jun-Mediated Neuronal Apoptosis. Molecular and Cellular Biology. 29(9). 2431–2442. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact